They exert beneficial effects on glucose and lipid metabolism and chronic inflammation through inhibition of histone deacetylation and/or binding to GPCRs such as GPR41, GPR43, and GPR109a [44], and reductions in their levels have been found to be associated with metabolic disorders or IBD [9]. The gene discussed is FFAR3; the disease is Other metabolic disease.